Dysbiosis of vaginal and cervical microbiome is associated with uterine fibroids

Dysbiosis of the female reproductive tract is closely associated with gynecologic diseases. Here, we aim to explore the association between dysbiosis in the genital tract and uterine fibroids (UFs) to further provide new insights into UF etiology. We present an observational study to profile vaginal and cervical microbiome from 29 women with UFs and 38 healthy women, and 125 samples were obtained and sequenced. By comparing the microbial profiles between different parts of the reproductive tract, there is no significant difference in microbial diversity between healthy subjects and UF patients. However, alpha diversity of UF patients was negatively correlated with the number of fibroids. Increased Firmicutes were observed in both the cervical and vaginal microbiome of UF patients at the phylum level. In differential analysis of relative abundance, some genera were shown to be significantly enriched (e.g., Erysipelatoclostridium, Mucispirillum, and Finegoldia) and depleted (e.g., Erysipelotrichaceae UCG-003 and Sporolactobacillus) in UF patients. Furthermore, the microbial co-occurrence networks of UF patients showed lower connectivity and complexity, suggesting reduced interactions and stability of the cervical and vaginal microbiota in UF patients. In summary, our findings revealed the perturbation of microbiome in the presence of UFs and a distinct pattern of characteristic vaginal and cervical microbiome involved in UFs, offering new options to further improve prevention and management strategies.

[1]  T. Tasca,et al.  Infinity war: Trichomonas vaginalis and interactions with host immune response , 2023, Microbial cell.

[2]  M. Serrano,et al.  Roles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health , 2022, Microbiology and molecular biology reviews : MMBR.

[3]  S. Askarova,et al.  Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan , 2022, Scientific Reports.

[4]  Xiaojun Ma,et al.  Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China , 2022, Frontiers in Microbiology.

[5]  Bo Li,et al.  Mycobiome Dysbiosis in Women with Intrauterine Adhesions , 2022, Microbiology spectrum.

[6]  H. Harris,et al.  The epidemiology of uterine fibroids: Where do we go from here? , 2022, Fertility and sterility.

[7]  N. Smargiasso,et al.  HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources , 2022, Nature Communications.

[8]  Seungok Lee,et al.  Clinical Significance of Composition and Functional Diversity of the Vaginal Microbiome in Recurrent Vaginitis , 2022, Frontiers in Microbiology.

[9]  Bin Zhang,et al.  Dysbiosis of Cervical and Vaginal Microbiota Associated With Cervical Intraepithelial Neoplasia , 2022, Frontiers in Cellular and Infection Microbiology.

[10]  D. Baird,et al.  Bacterial Vaginosis and Prospective Ultrasound Measures of Uterine Fibroid Incidence and Growth , 2022, Epidemiology.

[11]  M. Herbst-Kralovetz,et al.  The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. , 2021, Human reproduction update.

[12]  B. B. Finlay,et al.  Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women , 2021, Microbiology spectrum.

[13]  R. An,et al.  Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients , 2021, Frontiers in Cellular and Infection Microbiology.

[14]  D. Baird,et al.  Bacterial Vaginosis–Associated Bacteria and Uterine Fibroids: A Nested Case-Control Study , 2021, Sexually transmitted diseases.

[15]  A. Ellison,et al.  In silico trio-biomarkers for bacterial vaginosis revealed by species dominance network analysis , 2021, Computational and structural biotechnology journal.

[16]  Guilian Yang,et al.  Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection , 2021, Frontiers in Public Health.

[17]  S. Afrin,et al.  Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications , 2020, Stem Cell Reviews and Reports.

[18]  K. Hua,et al.  Types and viral load of human papillomavirus, and vaginal microbiota in vaginal intraepithelial neoplasia: a cross-sectional study , 2020, Annals of translational medicine.

[19]  Tae Jin Kim,et al.  Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection , 2020, PloS one.

[20]  D. Merico,et al.  Transcriptome-Wide Off-Target Effects of Steric-Blocking Oligonucleotides , 2020, bioRxiv.

[21]  Austin D. Swafford,et al.  Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection , 2020, The Journal of experimental medicine.

[22]  Yi-Xiang J. Wang,et al.  Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites , 2020, Gut.

[23]  C. Deveney,et al.  Daily Vaginal Microbiota Fluctuations Associated with Natural Hormonal Cycle, Contraceptives, Diet, and Exercise , 2020, mSphere.

[24]  J. Mukherjee,et al.  Assessing burden, risk factors, and perceived impact of uterine fibroids on women’s lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study , 2020, International Journal for Equity in Health.

[25]  Yang Bai,et al.  A practical guide to amplicon and metagenomic analysis of microbiome data , 2020, Protein & Cell.

[26]  Z. Ilhan,et al.  The microbiome and gynaecological cancer development, prevention and therapy , 2020, Nature Reviews Urology.

[27]  K. Nelson,et al.  Gastro-intestinal and oral microbiome signatures associated with healthy aging , 2019, GeroScience.

[28]  Francesco Asnicar,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[29]  J. H. van de Wijgert,et al.  Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. , 2019, American journal of obstetrics and gynecology.

[30]  Xi Shen,et al.  Dynamic construction of gut microbiota may influence allergic diseases of infants in Southwest China , 2019, BMC Microbiology.

[31]  Na Zhang,et al.  NRT1.1B is associated with root microbiota composition and nitrogen use in field-grown rice , 2019, Nature Biotechnology.

[32]  J. Moran-Gilad,et al.  Ecological dynamics of the vaginal microbiome in relation to health and disease , 2019, American journal of obstetrics and gynecology.

[33]  Liang Zhao,et al.  Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer , 2019, Cell Death & Differentiation.

[34]  B. Ata,et al.  The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls , 2019, Scientific Reports.

[35]  J. Morris Faculty Opinions recommendation of Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[36]  E. Myers,et al.  Uterine Fibroids: Burden and Unmet Medical Need , 2017, Seminars in Reproductive Medicine.

[37]  Huijue Jia,et al.  The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases , 2017, Nature Communications.

[38]  D. Baird,et al.  Self-reported bacterial vaginosis and risk of ultrasound-diagnosed incident uterine fibroid cases in a prospective cohort study of young African American women. , 2017, Annals of epidemiology.

[39]  S. Ghosh,et al.  Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System. , 2017, Cell metabolism.

[40]  C. Dutta,et al.  Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity , 2017, Front. Microbiol..

[41]  Ben Nichols,et al.  Distributed under Creative Commons Cc-by 4.0 Vsearch: a Versatile Open Source Tool for Metagenomics , 2022 .

[42]  J. Donnez,et al.  Uterine fibroid management: from the present to the future , 2016, Human reproduction update.

[43]  B. Tarlatzis,et al.  Infertility and uterine fibroids. , 2016, Best practice & research. Clinical obstetrics & gynaecology.

[44]  R. Fichorova,et al.  The Human Microbiome during Bacterial Vaginosis , 2016, Clinical Microbiology Reviews.

[45]  S. Cole,et al.  Self-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women. , 2015, Journal of women's health.

[46]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[47]  M. Blaut,et al.  Clostridium ramosum Promotes High-Fat Diet-Induced Obesity in Gnotobiotic Mouse Models , 2014, mBio.

[48]  E. C. Murphy,et al.  Gram-positive anaerobic cocci--commensals and opportunistic pathogens. , 2013, FEMS microbiology reviews.

[49]  R. Lillis,et al.  Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. , 2013, The Journal of infectious diseases.

[50]  Hauke Smidt,et al.  The function of our microbiota: who is out there and what do they do? , 2012, Front. Cell. Inf. Microbio..

[51]  H. Rangwala,et al.  Network‐Based Modeling of the Human Gut Microbiome , 2010, Chemistry & biodiversity.

[52]  Thomas L. Madden,et al.  BLAST+: architecture and applications , 2009, BMC Bioinformatics.

[53]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[54]  Mathieu Bastian,et al.  Gephi: An Open Source Software for Exploring and Manipulating Networks , 2009, ICWSM.

[55]  Y. Danieli Guide , 2005 .

[56]  S. Bulun,et al.  Uterine fibroids , 2001, The Lancet.

[57]  A. Gionis,et al.  Data Analysis , 1996, Data Sci. J..

[58]  A. Patel,et al.  The frequency of uterine leiomyomas. , 1990, American journal of clinical pathology.

[59]  Henry Knipe,et al.  Uterine Fibroids , 1903, The Hospital.

[60]  W. Catherino,et al.  Uterine fibroids , 2016, Nature Reviews Disease Primers.

[61]  J. Coon,et al.  Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. , 2015, Human reproduction update.

[62]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[63]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[64]  David B Dunson,et al.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. , 2003, American journal of obstetrics and gynecology.